Affirmation versus exploratory therapy

What is the difference between affirming and exploring a young person's gender distress, and what does the evidence say?

“Affirmation” and “exploration” are often presented as opposing approaches to a young person’s gender distress. In practice, the terms describe different emphases rather than two neatly separate clinical methods. Both should begin with kindness, safeguarding, and serious attention to distress. Neither should involve shaming a child for gender non-conformity, nor attempting to force a preferred identity.

Background

“Affirmation” and “exploration” are often presented as opposing approaches to a young person’s gender distress. In practice, the terms describe different emphases rather than two neatly separate clinical methods. Both should begin with kindness, safeguarding, and serious attention to distress. Neither should involve shaming a child for gender non-conformity, nor attempting to force a preferred identity.

An affirming approach generally treats a young person’s stated gender identity as valid and seeks to support them accordingly. This may involve using a chosen name or pronouns, helping schools reduce bullying, supporting social transition, and, in some settings, referring towards puberty blockers or cross-sex hormones after assessment. The American Academy of Pediatrics’ 2018 policy statement endorsed a gender-affirming model and distinguished it from “conversion” approaches intended to dissuade young people from identifying as transgender (AAP, 2018).

An exploratory approach does not presume that a stated identity is either mistaken or settled. It makes room to ask how gender distress has developed and what else may be relevant: puberty, sexuality, anxiety, depression, autism, trauma, family relationships, peer dynamics, body image, safeguarding concerns, and the young person’s hopes and fears. Exploration may lead a young person towards social or medical transition, away from it, or towards a period of uncertainty. Its ethical limit is important: exploration should not be a disguised attempt to make a gender-distressed child accept stereotypes or abandon an identity.

What the documents say

The strongest point of agreement across major documents is that young people need careful, developmentally appropriate assessment. WPATH’s Standards of Care Version 8 states that adolescent care should involve a comprehensive biopsychosocial assessment. It also recommends that clinicians address mental-health concerns that could interfere with diagnostic clarity, informed consent, or treatment before gender-affirming medical interventions are initiated (WPATH, 2022). Thus, even a leading affirming guideline does not formally endorse an assessment-free route to medical treatment.

The AAP’s 2018 statement similarly supported comprehensive, developmentally appropriate healthcare, including mental-health and family support. Its concern was that a model which begins from disbelief or aims to prevent a transgender identity can compound stigma and distress. That concern deserves weight: a distressed young person should not be treated as an ideological problem, or made to feel that they must prove their identity to receive ordinary compassion.

The evidence reviews commissioned by NHS England reached a more cautious conclusion about interventions and outcomes. NICE’s October 2020 review of gonadotrophin-releasing hormone analogues, commonly called puberty blockers, found the available evidence on gender dysphoria, mental health and quality of life to be of very low certainty (NICE, 2020). Very low certainty does not prove that treatment is ineffective. It means that the studies available cannot reliably establish the size, direction, or durability of benefit and harm.

The University of York’s systematic review of psychosocial support interventions found that the interventions, populations and outcome measures were too varied to identify a clear evidence-based therapeutic model (Heathcote et al., 2024). This matters for both sides of the debate. The evidence does not establish that a particular affirming therapeutic model resolves distress; equally, it does not establish that any particular exploratory therapy reliably does so.

Social transition is frequently described as wholly reversible because names, pronouns and clothing can be changed again. In a narrow physical sense, that is true. But it does not answer the clinical question of whether early social transition affects a child’s developmental pathway, family expectations, peer relationships, or future decisions. The University of York review of social transition included 11 studies, found most to be low quality, and reported no prospective longitudinal studies with appropriate comparator groups. It concluded that robust evidence of either benefit or harm was absent (Hall et al., 2024).

The Cass Review concluded that the evidence base for all interventions in this field was weak, including social transition, psychosocial support and endocrine treatment. Published on 10 April 2024, it recommended a holistic service model in which gender-related distress is considered alongside physical health, neurodevelopment, mental health, family circumstances and safeguarding (Cass Review, 2024). NHS England had already announced on 12 March 2024 that puberty blockers would no longer be routinely commissioned for children and young people with gender incongruence or dysphoria.

Other public health bodies had moved in a similarly cautious direction. In February 2022, Sweden’s National Board of Health and Welfare stated that scientific evidence did not permit secure conclusions about the effects and safety of hormonal treatments for minors, and judged that, at population level, risks then outweighed possible benefits. It advised that treatment should generally be provided within research, with exceptional individual cases considered separately (Socialstyrelsen, 2022).

Legal findings should not be confused with clinical evidence. In Bell v Tavistock, the High Court’s December 2020 judgment raised concerns about young people’s capacity to consent to puberty blockers. The Court of Appeal overturned that ruling on 17 September 2021, holding that the question of Gillick competence belonged to clinicians rather than a general court declaration. The appeal judgment did not decide that puberty blockers were clinically effective or ineffective (Bell v Tavistock, 2021).

The positions

Supporters of an affirming model argue that trans and gender-diverse young people face real distress, stigma and elevated mental-health risks. They maintain that prompt respect, family support and access to specialist care can reduce isolation. They also argue that excessive gatekeeping may prolong distress, particularly for adolescents whose dysphoria is persistent and whose experience of puberty is acutely distressing. Critics of recent UK policy argue that the Cass Review and its evidence reviews applied standards that are difficult to meet in paediatric care, where randomised trials may be ethically and practically challenging.

Supporters of exploratory care reply that compassion does not require clinicians to treat identity as a diagnosis with a predetermined treatment pathway. They emphasise that young people presenting today are heterogeneous, and that a clinician should understand the whole picture before endorsing social or medical steps with potentially significant consequences. They argue that uncertainty in the evidence is especially important where interventions can affect fertility, sexual development, bone health, lifelong medication use, or future bodily options.

There is also a legitimate methodological dispute. The Yale Integrity Project’s 2024 critique argued that the Cass Review and its linked reviews contained methodological flaws and gave insufficient weight to some evidence. That critique does not remove the underlying problem identified by NICE, Sweden and Cass: long-term comparative evidence remains limited. It does show why public bodies should publish methods, evidence tables and reasoning clearly enough to permit rigorous challenge.

Interpretation

Beyond Gender’s reading is that the central contrast is not kindness versus cruelty. A genuinely exploratory approach should affirm the young person’s dignity, protect them from bullying, and take their distress seriously. What it should not do is convert an initial declaration of identity into a clinical conclusion before the young person’s circumstances have been understood.

Affirmation becomes problematic when it means affirming one explanation for distress while discouraging curiosity about others. For a child who is distressed by puberty, uncomfortable with sex stereotypes, same-sex attracted, autistic, traumatised, depressed, or struggling with body image, gender may be highly relevant without being the only relevant factor. Those possibilities are not reasons to deny a trans identity; they are reasons to assess rather than assume.

The current evidence does not justify claims that medical transition is known to be either universally harmful or reliably life-saving for the broad and changing population now referred to services. Nor does it justify treating social transition or medical intervention as neutral defaults. Where the evidence is uncertain and the potential consequences can be substantial, open-ended therapeutic exploration, careful follow-up, and proportionate treatment of co-occurring difficulties are the more defensible starting points.

Open questions

Better research is needed on which young people experience persistent gender dysphoria, which interventions help particular subgroups, and what outcomes look like over five, ten and more years. Studies should distinguish childhood-onset and adolescent-onset presentations, record co-occurring conditions, include those who discontinue treatment or detransition, and measure outcomes beyond identity labels alone.

There is also a need for direct research into therapeutic practice. “Exploratory therapy” should be defined clearly and tested for benefit, safety and acceptability. So should affirming psychosocial support. Young people and families deserve more than slogans from either side: they deserve honest consent processes, respectful clinicians, meaningful alternatives, and evidence capable of guiding individual care.

On the timeline

Episodes on this idea

Where Did Psychotherapy Go Wrong? | Ian Cox

Why Anorexia is Just Like Gender Dysphoria...? A Conversation with Deanne Jade

Differences Between Boys and Girls with Dr. Michael Gurian